To evaluate the clinical relevance of E2F1, E2F7, and MYBL2 in GC, we used the Kaplan–Meier Plotter online tool to establish correlations between their mRNA levels and the prognosis of patients with GC. Here, E2F1 is linked to gastric cancer.